Clinically Applicable Magnetic-Labeling of Natural Killer Cells for MRI of Transcatheter Delivery to Liver Tumors: Preclinical Validation for Clinical Translation

Kangan Li,Andrew C. Gordon,Linfeng Zheng,Weiguo Li,Yang Guo,Jing Sun,Guixiang Zhang,Guohong Han,Andrew C. Larson,Zhuoli Zhang
DOI: https://doi.org/10.2217/nnm.15.24
2015-01-01
Nanomedicine
Abstract:Aim: To test the hypothesis that MRI can monitor intraportal vein (IPV) transcatheter delivery of clinically applicable heparin-protamine-ferumoxytol (HPF) nanocomplex-labeled natural killer (NK) cells to liver tumor. Materials & methods: Liver tumor rat models underwent catheterization for IPV infusion of HPF-labeled NK cells (NK-92MI cell line). MRI measurements within tumor and adjacent liver tissues were compared pre- and post-NK cell infusion. Histology studies were used to identify NK cells in the target tumors. Results: For first time, we demonstrated that MRI tracks HPF-labeled NK cells migration within liver following IPV delivery. Conclusion: IPV transcatheter infusion permitted selective delivery of NK cells to liver tissues and MRI allowed tracking NK cell biodistributions within the tumors.
What problem does this paper attempt to address?